Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

BACKGROUND: Myeloablative chemoradiotherapy and immunomagnetically purged autologous bone marrow transplantation has been shown to improve outcome for patients with high-risk neuroblastoma. Currently, peripheral blood stem cells (PBSC) are infused after myeloablative therapy, but the effect of purgi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kreissman, Susan G, Seeger, Robert C, Matthay, Katherine K, London, Wendy B, Sposto, Richard, Grupp, Stephan A, Haas-Kogan, Daphne A, LaQuaglia, Michael P, Yu, Alice, Diller, Lisa, Buxton, Allen, Park, Julie R, Cohn, Susan L, Maris, John M, Reynolds, C Patrick, Villablanca, Judith G
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3963485/
https://ncbi.nlm.nih.gov/pubmed/23890779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(13)70309-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky